Dergiler / Medicine Science / 2015 / Cilt: 4 - Sayı: 4

May Ursodeoxycholic Acid Significantly Improve Liver Function Tests among Patients with Hepatitis C?

Sayfa
2986–2988
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, there are some concerns that need to be explained in a detailed manner for a better understanding of the results presented in the manuscript.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:In their relevant study, the authors demonstrated that ursodeoxycholic acid therapy significantly improvedliver function tests either when given alone or combined with silymarin.
📊
Temel Bulgular & Veri:But, silymarin itself failed to improve liver function tests.
💡
Sonuç & Katkı:However, there are some concerns that need to be explained in a detailed manner for a better understanding of the results presented in the manuscript.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

In their relevant study, the authors demonstrated that ursodeoxycholic acid therapy significantly improvedliver function tests either when given alone or combined with silymarin. But, silymarin itself failed to improve liver function tests. We thank to the authors for their valuable contribution. However, there are some concerns that need to be explained in a detailed manner for a better understanding of the results presented in the manuscript.

🔖

Bu Makaleye Atıf Yap

TANOĞLU, A., SAVAŞCI, Ü., KARAGÖZ, E. (2015). May Ursodeoxycholic Acid Significantly Improve Liver Function Tests among Patients with Hepatitis C?. Medicine Science, Cilt: 4 - Sayı: 4, 2986–2988. https://ajindex.com/articles/277793

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. El Menshawe SF, Ahmed AS, Abdelaty LN, Aty LNA, Abo Seif MA. Study of hepatoprotective effect of silymarin and ursodeoxycholic acid in chronic Hepatitis C Patients. Med-Science. 2014;3(4):1655-74. 2. Coppola A, DiCapua M, Conca P. Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do westand? Semin Thromb Hemost. 2013;39(7):803-15. 3. Konerman MA, Yapali S, Lok AS. Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring-predictors and predictive models of disease progression Aliment Pharmacol Ther. 2014;40(8):863-79.